• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Efficacy and safety of Danggui Buxue Decoction in combination with western medicine treatment of anemia for renal anemia: a systematic review and meta-analysis.当归补血汤联合西药治疗肾性贫血的疗效与安全性:一项系统评价与Meta分析
Ann Transl Med. 2017 Mar;5(6):136. doi: 10.21037/atm.2017.01.17.
2
Danggui Buxue Tang, Chinese Herbal Decoction Containing Astragali Radix and Angelicae Sinensis Radix, Induces Production of Nitric Oxide in Endothelial Cells: Signaling Mediated by Phosphorylation of Endothelial Nitric Oxide Synthase.当归补血汤,一种含有黄芪和当归的中药汤剂,可诱导内皮细胞产生一氧化氮:由内皮型一氧化氮合酶磷酸化介导的信号传导。
Planta Med. 2016 Mar;82(5):418-23. doi: 10.1055/s-0035-1558332. Epub 2016 Jan 29.
3
Ferulic acid enhances the chemical and biological properties of astragali radix: a stimulator for danggui buxue tang, an ancient Chinese herbal decoction.阿魏酸增强了黄芪的化学和生物学特性:一种古代中药方剂当归补血汤的刺激剂。
Planta Med. 2014 Feb;80(2-3):159-64. doi: 10.1055/s-0033-1360314. Epub 2014 Jan 31.
4
Rapid chemical characterization of Danggui Buxue decoction using processed Astragali Radix and Angelicae Sinensis Radix based on diagnostic ion and molecular network.基于特征离子和分子网络的当归补血汤中炮制黄芪和当归的快速化学特征分析。
Biomed Chromatogr. 2023 Aug;37(8):e5640. doi: 10.1002/bmc.5640. Epub 2023 Apr 23.
5
[Review of chemical constituents,pharmacological effects and clinical applications of Danggui Buxue Decoction and prediction and analysis of its Q-markers].[当归补血汤的化学成分、药理作用及临床应用综述及其Q-标志物的预测与分析]
Zhongguo Zhong Yao Za Zhi. 2021 Jun;46(11):2677-2685. doi: 10.19540/j.cnki.cjcmm.20200828.201.
6
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer.探索当归补血汤治疗IBD相关结直肠癌的免疫代谢潜力。
Chin Med. 2024 Aug 29;19(1):117. doi: 10.1186/s13020-024-00978-y.
7
Danggui Buxue Tang (Astragali Radix and Angelicae Sinensis Radix) for menopausal symptoms: A review.当归补血汤(黄芪和当归)治疗更年期症状:综述。
J Ethnopharmacol. 2017 Mar 6;199:205-210. doi: 10.1016/j.jep.2017.01.044. Epub 2017 Feb 2.
8
A specific SNP-based multiplex PCR assay for the simultaneous identification of two biological ingredients for the Chinese patent medicine, Danggui Buxue pill.一种基于单核苷酸多态性的多重聚合酶链反应检测方法,用于同时鉴定中成药当归补血丸的两种生物成分。
Front Pharmacol. 2023 May 11;14:1098598. doi: 10.3389/fphar.2023.1098598. eCollection 2023.
9
Calycosin orchestrates the functions of Danggui Buxue Tang, a Chinese herbal decoction composing of Astragali Radix and Angelica Sinensis Radix: An evaluation by using calycosin-knock out herbal extract.毛蕊异黄酮调控当归补血汤(由黄芪和当归组成的中药方剂)的功能:使用毛蕊异黄酮敲除草药提取物进行评估。
J Ethnopharmacol. 2015 Jun 20;168:150-7. doi: 10.1016/j.jep.2015.03.033. Epub 2015 Mar 19.
10
Danggui Buxue Decoction: Comparative pharmacokinetic research on six bio-active components in different states by ultra-performance liquid chromatography-tandem mass spectrometry after oral administration.当归补血汤:口服给药后不同状态下六种生物活性成分的超高效液相色谱-串联质谱比较药代动力学研究。
J Sep Sci. 2023 Mar;46(6):e2200794. doi: 10.1002/jssc.202200794. Epub 2023 Jan 29.

引用本文的文献

1
Effect of add-on therapy with Traditional Chinese Medicine on the survival of patients with anemic lower-risk myelodysplastic syndromes in the real-world setting: a retrospective study.在真实世界中,中药辅助治疗对贫血性低危骨髓增生异常综合征患者生存的影响:一项回顾性研究。
J Tradit Chin Med. 2025 Feb;45(1):152-159. doi: 10.19852/j.cnki.jtcm.2025.01.014.
2
Conventional and complementary alternative medicine therapies for renal anemia: a literature review.肾性贫血的传统及补充替代医学疗法:文献综述
Front Endocrinol (Lausanne). 2025 Jan 22;15:1342873. doi: 10.3389/fendo.2024.1342873. eCollection 2024.
3
The Latest Research Advances of Danggui Buxue Tang as an Effective Prescription for Various Diseases: A Comprehensive Review.当归补血汤作为治疗各种疾病的有效方剂的最新研究进展:全面综述。
Curr Med Sci. 2022 Oct;42(5):913-924. doi: 10.1007/s11596-022-2642-0. Epub 2022 Oct 17.
4
Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-1/Smad3 Signaling.黄芪甲苷IV与阿魏酸协同通过TGF-β1/Smad3信号通路改善肺纤维化
Evid Based Complement Alternat Med. 2021 Mar 2;2021:8845798. doi: 10.1155/2021/8845798. eCollection 2021.
5
Erythropoietin combined with traditional Chinese medicine for chemotherapy-induced anemias: A protocol of systematic review and meta-analysis.促红细胞生成素联合中药治疗化疗所致贫血:系统评价与Meta分析方案
Medicine (Baltimore). 2020 Oct 30;99(44):e22799. doi: 10.1097/MD.0000000000022799.
6
Effects of Jianpi Bushen Therapy for Treatment of CKD Anemia: A Meta-Analysis of Randomized Controlled Trials.健脾补肾疗法治疗慢性肾脏病贫血的疗效:一项随机对照试验的Meta分析
Front Pharmacol. 2020 Sep 15;11:560920. doi: 10.3389/fphar.2020.560920. eCollection 2020.
7
Knowledge Mapping of (Danggui) Research: A Scientometric Study.(当归)研究的知识图谱:一项科学计量学研究。
Front Pharmacol. 2020 Mar 13;11:294. doi: 10.3389/fphar.2020.00294. eCollection 2020.
8
Repressed Exercise-Induced Hepcidin Levels after Danggui Buxue Tang Supplementation in Male Recreational Runners.当归补血汤补充剂对男性业余跑步者运动诱导的铁调素水平的抑制作用。
Nutrients. 2018 Sep 18;10(9):1318. doi: 10.3390/nu10091318.
9
Correction of Anemia in Chronic Kidney Disease With Polysaccharide via Restoring EPO Production and Improving Iron Availability.通过恢复促红细胞生成素的产生和改善铁的可利用性,用多糖纠正慢性肾脏病中的贫血。
Front Pharmacol. 2018 Jul 31;9:803. doi: 10.3389/fphar.2018.00803. eCollection 2018.
10
Effectiveness of Chinese Herbal Medicine Combined with Antibiotics for Extensively Drug-Resistant Enterobacteria and Nonfermentative Bacteria Infection: Real-Life Experience in a Retrospective Cohort.中药联合抗生素治疗广泛耐药肠杆菌科细菌和非发酵菌感染的疗效:回顾性队列研究中的真实经验。
Biomed Res Int. 2017;2017:2897045. doi: 10.1155/2017/2897045. Epub 2017 Oct 11.

本文引用的文献

1
Quality Control of Danggui Buxue Tang, a Traditional Chinese Medicine Decoction, by (1)H-NMR Metabolic Profiling.采用(1)H-NMR 代谢组学方法对当归补血汤进行质量控制。
Evid Based Complement Alternat Med. 2014;2014:567893. doi: 10.1155/2014/567893. Epub 2014 Mar 23.
2
Ferulic acid enhances the chemical and biological properties of astragali radix: a stimulator for danggui buxue tang, an ancient Chinese herbal decoction.阿魏酸增强了黄芪的化学和生物学特性:一种古代中药方剂当归补血汤的刺激剂。
Planta Med. 2014 Feb;80(2-3):159-64. doi: 10.1055/s-0033-1360314. Epub 2014 Jan 31.
3
Effect of Danggui Buxue Tang on immune-mediated aplastic anemia bone marrow proliferation mice.当归补血汤对免疫介导的再生障碍性贫血骨髓增殖小鼠的影响。
Phytomedicine. 2014 Apr 15;21(5):640-6. doi: 10.1016/j.phymed.2013.10.018. Epub 2013 Nov 27.
4
Erythropoietic agents from natural sources.
Altern Ther Health Med. 2013 Nov-Dec;19(6):54-60.
5
Renal anemia: a nephrologist's view.肾性贫血:肾脏病学家的观点。
Hippokratia. 2011 Jan;15(Suppl 1):39-43.
6
Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy.黄芪甲苷与阿魏酸联用抑制梗阻性肾病大鼠肾小管间质纤维化。
Br J Pharmacol. 2011 Apr;162(8):1805-18. doi: 10.1111/j.1476-5381.2011.01206.x.
7
Polysaccharides from the root of Angelica sinensis promotes hematopoiesis and thrombopoiesis through the PI3K/AKT pathway.当归根多糖通过 PI3K/AKT 通路促进造血和血小板生成。
BMC Complement Altern Med. 2010 Dec 21;10:79. doi: 10.1186/1472-6882-10-79.
8
Chemical composition and inhibitory effect on hepatic fibrosis of Danggui Buxue Decoction.当归补血汤的化学成分及其对肝纤维化的抑制作用。
Fitoterapia. 2010 Oct;81(7):793-8. doi: 10.1016/j.fitote.2010.04.007. Epub 2010 May 6.

当归补血汤联合西药治疗肾性贫血的疗效与安全性:一项系统评价与Meta分析

Efficacy and safety of Danggui Buxue Decoction in combination with western medicine treatment of anemia for renal anemia: a systematic review and meta-analysis.

作者信息

Zhao Ming-Ming, Zhang Yu, Li Liu-Sheng, Yu Zi-Kai, Li Bo

机构信息

Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China.

出版信息

Ann Transl Med. 2017 Mar;5(6):136. doi: 10.21037/atm.2017.01.17.

DOI:10.21037/atm.2017.01.17
PMID:28462216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5395475/
Abstract

BACKGROUND

To evaluate the efficacy and safety of Danggui Buxue Decoction for renal anemia when combined with western medicine treatment of anemia.

METHODS

Electronic searching Medline, Embase, Web of Science, Cochrane Library, Chinese BioMedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), WanFang data, Chinese Sci-tech periodical full-text database (VIP). Randomized controlled trials reported results of efficacy and safety of Danggui Buxue Decoction in combination with western medicine treatment of anemia for renal anemia. The "risk of bias assessment tool (Version 5.1.0)" of Cochrane Handbook was applied to assess the quality of included trials and RevMan 5.3 software was used for data analysis.

RESULTS

A total of 111 studies was retrieved, seven studies including 460 cases were included, the methodological quality of included trials was poor. The result of meta-analysis demonstrated that there was no difference in hemoglobin (Hb) [weighted mean differences (WMD) =-8.75, 95% confidence interval (CI): (-18.64, 1.13), P=0.08], whereas the subgroup analysis showed the difference was significant when the ratio of Radix Astragali to Radix Angelicae Sinensis was 5:1 [WMD =-16.27, 95% CI: (-28.73, -3.80), P=0.01], increase of Hb was more effective in experimental group than control group and the difference was not significant when the ratio of Radix Astragali to Radix Angelicae Sinensis was 5≠1 [WMD =-0.57, 95% CI: (-4.52, 3.39), P=0.78]. There were significant differences in red blood cell (RBC) [WMD =-0.49, 95% CI: (-0.69, -0.28), P<0.00001], hematocrit (HCT) [WMD =-1.92, 95% CI: (-3.15, -0.69), P=0.002] and clinical efficacy [odd ratio (OR) =0.30, 95% CI: (0.13, 0.69), P=0.004] between Danggui Buxue Decoction combination group and control group, the experimental group was better than control group. There was no adverse event reported in the experimental group.

CONCLUSIONS

Danggui Buxue Decoction in combination with conventional western medicine (CWM) for renal anemia might be superior to CWM alone and there was no adverse event in the experimental group, it might be more effective when the ratio of Radix Astragali to Radix Angelicae Sinensis was 5:1. However, the quality of included studies was not high, and less attention was paid to the safety, high quality randomized controlled trials are needed to further confirm the findings.

摘要

背景

评估当归补血汤联合西药治疗肾性贫血的疗效和安全性。

方法

电子检索Medline、Embase、Web of Science、Cochrane图书馆、中国生物医学文献数据库(CBM)、中国知网(CNKI)、万方数据、中文科技期刊全文数据库(VIP)。随机对照试验报告了当归补血汤联合西药治疗肾性贫血的疗效和安全性结果。应用Cochrane手册的“偏倚风险评估工具(5.1.0版)”评估纳入试验的质量,并使用RevMan 5.3软件进行数据分析。

结果

共检索到111项研究,纳入7项研究共460例,纳入试验的方法学质量较差。Meta分析结果显示,血红蛋白(Hb)差异无统计学意义[加权均数差(WMD)=-8.75,95%置信区间(CI):(-18.64,1.13),P=0.08],而亚组分析显示,当黄芪与当归比例为5∶1时差异有统计学意义[WMD=-16.27,95%CI:(-28.73,-3.80),P=0.01],试验组Hb升高效果优于对照组;当黄芪与当归比例不为5∶1时差异无统计学意义[WMD=-0.57,95%CI:(-4.52,3.39),P=0.78]。当归补血汤联合组与对照组在红细胞(RBC)[WMD=-0.49,95%CI:(-0.69,-0.28),P<0.00001]、血细胞比容(HCT)[WMD=-1.92,95%CI:(-3.15,-0.69),P=0.002]和临床疗效[比值比(OR)=0.30,95%CI:(0.13,0.69),P=0.004]方面差异有统计学意义,试验组优于对照组。试验组未报告不良事件。

结论

当归补血汤联合传统西药治疗肾性贫血可能优于单纯西药治疗,且试验组无不良事件,当黄芪与当归比例为5∶1时可能更有效。然而,纳入研究的质量不高,对安全性的关注较少,需要高质量的随机对照试验进一步证实该结果。